Priority Jewels IPO: A Better Business or Just Better Numbers?

Quick Summary: Priority Jewels is a B2B manufacturer of lightweight diamond-studded jewellery whose revenue grew 31% in two years while its gold output fell 21%. The improving numbers are real, but they blend genuine export-led volume, mix and commodity effects, a one-time debt repayment and an interest-free promoter loan. Reported profit has not yet converted into cash.

Anyone who has read a jewellery IPO prospectus in the last three years has seen the template: a fast-growing niche, a large addressable market, improving margins, a credible management story. Priority Jewels fits the template almost perfectly, which is exactly why it deserves the closer read. The headline numbers are genuinely improving. The question is what they are made of, and some of the ingredients are not what the growth story implies.

Priority Jewels is a Mumbai-based manufacturer that makes lightweight, affordable diamond-studded gold and platinum jewellery and sells it wholesale to the country's largest jewellery chains. It has no stores, no consumer brand and no job-work line. Its customers include CaratLane, Kalyan Jewellers, Reliance Retail, Malabar Gold and Diamonds FZCO, TBZ and Senco, and its exports reach 13 countries. Over FY24 to FY26 its revenue grew from ₹410.51 crore to ₹538.95 crore, its EBITDA margin improved from 4.71% to 6.24%, and its return on equity roughly doubled to 14.49%. Those are the numbers the story is built on. This article is about what sits underneath them.

What Priority Jewels actually is

The company sits in the middle of the jewellery value chain. On one side are gold, diamond and stone suppliers; on the other are the retailers who sell to consumers. Priority buys the raw material, manufactures on its own account, and sells finished lightweight diamond-studded jewellery wholesale. It does not make jewellery on a retailer's gold (job work) and it does not sell to end consumers.

That position is structurally favoured by the industry's make-versus-buy logic. TBZ works with more than 150 external gold vendors. Senco outsources more than 75% of its production to karigars. Industry-wide, organised jewellers outsource an estimated 70-75% of manufacturing. The reasons are cost and quality: an integrated manufacturer controls metal loss, uses gold metal loans to fix prices, carries BIS hallmarking and third-party diamond certification, and turns around designs faster than a chain's own workshops.

The niche itself is attractive. Lightweight diamond-studded daily-wear jewellery carries more value per gram than plain gold, which makes the revenue less dependent on physical gold throughput, and it is a repeat-purchase category rather than a wedding-cycle one. Priority's differentiation rests on a 39-person in-house design team, 8,356 new designs in FY26 (up 59.8% from FY24), CAD/CAM with 3D printing, and customer relationships that the prospectus says go back 8 to 16 years. Those are capabilities retailers demonstrably buy rather than replicate.

The improvement is real. What is driving it is the question

The financial trajectory, as restated in the offer document, is the foundation of the entire story:

Growth is accelerating, not decelerating: FY25 revenue rose 6.1%, FY26 rose 23.8%. Revenue compounded at 14.58% over the two years while PAT compounded at roughly 57%, from ₹7.15 crore to ₹17.65 crore. EBITDA grew 38.5% in FY26, about 1.6 times as fast as revenue, because employee costs and depreciation grew far more slowly than sales. Return on equity went from 7.35% to 14.49% on an average basis, and return on capital employed from 17.47% to 25.36%. Exports jumped 67% in FY26 to ₹264.80 crore, or 49.1% of revenue.

Every one of those statements is true. The analytical work starts now, because each one can also be read differently: the growth is partly mix and commodity-price movement rather than throughput, the margin improvement is partly a capital-structure effect, and the profit has not been followed by cash.

Revenue climbed 31% in two years. Gold output fell 21%

This is the first contradiction in the story, and the most revealing one. Over FY24 to FY26, revenue grew 31.3% (₹410.51 crore to ₹538.95 crore). Physical production by weight fell 21.0%, from 580 kg to 458 kg. Capacity utilisation fell from 83% to 65%, and then to 58% annualised in Q1 FY27.

The reconciliation has three parts, and they matter in different ways.

First, volume is real but modest. Units processed grew from 1,72,108 to 2,03,860, an 8.83% CAGR. Against a 14.58% revenue CAGR, the residual is a price/mix component of roughly 5.3% a year. Revenue per unit rose from ₹23,852 to ₹26,437, up 10.8% over the two years. That is an estimated split, because the prospectus does not separately disclose price and mix, but the arithmetic is simple: revenue growth minus unit growth leaves price/mix.

Second, the mix is the interesting part. The diamonds and stones segment grew 43.8% over the two years (₹147.79 crore to ₹212.47 crore), against 24.6% for finished jewellery (₹241.38 crore to ₹300.68 crore). It went from about 38% to about 41% of product revenue, and export diamonds and stones nearly doubled. Revenue per kilogram of gold rose 66.3%, from ₹0.708 crore to ₹1.177 crore, because the pieces are lighter and carry more diamond content. This is a genuine product-line shift, not an accounting artefact.

Third, gold price did not inflate the top line the way one might assume. The national average gold import price rose about 87% over the same two years, far faster than the company's 31% revenue growth. If anything, the commodity tailwind outpaced the company; the growth was won through lighter pieces, diamond content and export mix, not by riding the gold price.

What this means for the utilisation paradox: falling utilisation by weight is partly a mix artefact. More, lighter, higher-diamond-content pieces per kilogram is the whole strategy. But it is also a signal. The fastest-growing lines, export diamonds and stones, do not pass through the 700 kg gold plant at all, and the prospectus does not disclose how much of that segment is trading versus manufacturing. The growth engine is migrating away from the manufacturing asset, which is exactly why the company's own capacity metric is becoming less informative.

That makes the capacity expansion the strangest line in the document. The company is "in the process of adding floors" to its MIDC facility in Andheri East, and says it will need additional machinery, to be funded "primarily from our internal accruals". No investment amount, no expected capacity, no timeline and no order visibility are disclosed. The offer document itself lists under-utilisation of expanded capacity as a risk. Meanwhile, capex has been modest, ₹1.23 crore in FY24 and ₹3.37 crore in FY26, with ₹1.90 crore spent in Q1 FY27 alone and ₹2.07 crore sitting in capital work in progress.

Holding the FY26 revenue per kilogram constant, the existing 700 kg plant at 80% utilisation supports roughly ₹659 crore of revenue, versus ₹538.95 crore in FY26, and ₹824 crore at 100%. There is a 30-50% revenue runway on the plant as it stands today. The expansion is a bet on demand that has not yet shown up in throughput, and the bet is being placed at the same time the utilisation number is falling.

Profit is up. Cash is not following

The second contradiction is between the income statement and the cash flow statement. Reported PAT more than doubled over two years. Operating cash flow did not keep up.

In FY24 the company generated negative operating cash on a profit. In FY25 it converted a quarter of its profit into cash. FY26 was the one clean year, helped by a large receivable collection. Q1 FY27 swung back to negative: operating cash flow of minus ₹6.10 crore on a pre-tax profit of ₹8.54 crore, driven by an ₹8.75 crore inventory build and an ₹8.87 crore receivables build in a single quarter.

The working-capital engine explains it. The cash conversion cycle ran at 167 days in FY24, 172 in FY25, 148 in FY26 and 145 days in Q1 FY27. Inventory stood at ₹130.39 crore at June 2026, up 21% from ₹107.73 crore fifteen months earlier, even as inventory holding days fell. Receivables are healthy in ageing terms, 99.2% current, but they are large. About 87.56% of the company's total borrowings of ₹112.74 crore at June 2026 were secured working-capital loans. In other words, the balance sheet is a revolving fund for inventory and receivables, and that fund has absorbed cash in three of the four most recent reported periods.

The question this raises is the central one for earnings quality: the profit improvement is partly real operating gains, but it has not yet shown up as cash, and the debt structure is the mechanism through which growth is financed.

The IPO repays ₹75 crore of bank debt and keeps the ₹13 crore promoter loan

The offer is a 100% fresh issue with no offer for sale. Promoters sell nothing. The objects allocate roughly ₹75 crore, about 75% of net proceeds, to repay working-capital borrowings, with the balance to general corporate purposes. No capex is allocated. Four loans are named for repayment: Axis at 8.25%, HDFC at 4-8%, Yes Bank at 4-8.3% and Central Bank of India at 8.75%.

The interest saving is meaningful but it is a one-time step-up, not a durable growth engine. At those rates, repaying ₹75 crore saves roughly ₹3.0 to ₹6.6 crore a year, or about 17% to 37% of FY26 PAT. Total borrowings would fall from ₹112.74 crore to roughly ₹37.7 crore, and working-capital loans from about ₹98.7 crore to about ₹23.7 crore. Debt to equity would drop from 0.76x toward far lower levels, and net debt to EBITDA had already fallen from 5.68x in FY24 to 2.86x in FY26.

The catch is that the debt is structural, not cyclical. A 145-172 day cash conversion cycle that absorbed cash in three of four periods will re-borrow the moment inventory and receivables grow again. The facilities are still in place. The repayment compresses the funding buffer temporarily; the engine that built the debt is untouched.

Then there is the promoter loan, the most underappreciated item in the entire document. The managing director and chairman, Shailesh Sangani, has lent the company money that is interest-free, unsecured and repayable on demand. The balance was ₹30.34 crore at FY25-end, ₹18.01 crore at FY26-end and ₹13.08 crore at June 30, 2026. Tranches have been drawn since October 2022, and new money was still being drawn in Q1 FY27 (₹5.24 crore drawn against ₹10.17 crore repaid). No demand for repayment has been made in any period.

That is a subsidy, not an arm's-length arrangement. If the same balance had been funded at a market rate of about 8%, the finance cost would have been roughly ₹2.43 crore a year at the peak balance and about ₹1.05 crore today, or up to about 14% of FY26 PAT at the peak. Reported profitability is partly a function of zero-cost related-party capital.

The economically unusual detail is the combination of two disclosures that are never put together. The IPO repays ₹75 crore of bank debt with new investors' money, which lifts reported EPS through interest savings. And the general corporate purposes are explicitly barred from repaying promoter or director loans. The structure retires the arm's-length borrowings while preserving the zero-cost related-party subsidy. If that loan is ever called or repriced to market, the profit base loses up to roughly 14% of its peak-period value, on top of a business whose cash conversion has historically been weak.

The largest customer halved. Exports doubled. Concentration is falling and deepening at once

Customer concentration is the risk most visible on the surface, and the data beneath it is more subtle than the trend line suggests.

The top-10 concentration fell from 57.72% to 47.92% over two years, and five new corporate clients were added in FY25. That is genuine diversification. But the largest customer also shrank in absolute terms, by about 35.8% between FY25 and FY26, from ₹87.69 crore to ₹56.27 crore. The halving of its share from 20.14% to 10.44% is not only a denominator effect; it is a real reduction in business from the single largest account. The prospectus withholds the customer's identity "due to confidentiality reasons", and the six named key clients are illustrative, not mapped to the customer numbers, so it is not possible to say whether this was deliberate de-risking, a switch, or a lost account. The company absorbed the loss without losing overall growth, which is the strongest counterargument.

The concentration is layered. Maharashtra has been 69-74% of domestic revenue in FY24-FY26, falling to 58.19% in Q1 FY27. The UAE is about 37-41% of export revenue across the same period and roughly 18% of total revenue in FY26. The single largest export customer, Malabar Gold and Diamonds FZCO in Dubai, is among the named clients and may well be the top customer, though the prospectus does not say so. Customer, geography and export-market concentration are therefore not independent risks; they can move together.

There are no exclusive or long-term contracts with any customer. The relationships are relationship- and capability-driven, not contractually locked in, which is normal in this industry but means any account decision by a large chain is an unhedged event.

Exports deserve their own look, because they are the growth engine and the exposure at the same time:

The quality of the +67% export growth is better than it first looks. It was broad-based, with Belgium entering the top five, the United States growing steadily, and the "all other" bucket up 388%, which cut the top-5 concentration from 95.4% to 86.7%. Both product legs contributed: finished jewellery exports rose 54% to ₹126.54 crore and diamonds and stones exports rose 74% to ₹129.45 crore. The company serves more than 200 customers across 13 countries, and the prospectus says most exports go to overseas stores of Indian jewellery chains, primarily catering to the Indian diaspora, with the India-UAE trade agreement as a structural tailwind.

Three caveats temper the export story. The UAE remains 37.5% of exports and the Malabar relationship is the anchor of that channel. The United States, about 12.8% of exports, carries tariff risk that the prospectus itself flags (a 50% US tariff on the relevant categories), and roughly a third of India's gems and jewellery exports go to the US at the industry level. And the single most important unknown is undisclosed: the prospectus does not disclose export versus domestic margins. FY25 commentary attributed profit growth to higher-margin domestic revenue, which is the opposite of the usual export-premium assumption, so it cannot be verified that the export-led growth is margin-accretive.

Why RBZ earns 14% and Priority earns 6%

The peer comparison that every reader of this IPO will see is the one against listed jewellery manufacturers, and it needs to be read carefully, because the models are different:

RBZ's 14.44% EBITDA margin is not a benchmark Priority can chase, because it is a different business. RBZ blends wholesale with roughly a third of sales in retail, where gross margins are estimated at 12-14% against 6-8% wholesale, plus a job-work line that earns margin on retailer-supplied gold with almost no raw-material investment, and its core product is antique bridal jewellery, which the company itself describes as the highest-margin category within gold. Priority has none of those three. It is pure wholesale manufacturing plus a diamonds-and-stones line that is about 41% of product revenue and includes trading-style pass-through revenue with an undisclosed margin. A pass-through line mechanically caps the blended margin; it is the opposite of RBZ's high-margin mix. Finance cost does not explain the EBITDA gap either, since it hits the PAT line, not the EBITDA line, though Priority's higher leverage (0.74x versus 0.35x and 0.47x for peers) does drag its net margin.

The realistic reference band is Khazanchi and Ashapuri at 7-8%, and Priority is already at 7.01% in Q1 FY27. The arithmetic of getting further matters. On the FY26 revenue base, reaching a 7% EBITDA margin needs ₹4.1 crore more EBITDA (up 12%), 8% needs ₹9.5 crore (up 28%), and 10% needs ₹20.3 crore (up 60%). No disclosed roadmap of that magnitude exists. Volume growth alone cannot do it: at 80% utilisation the revenue base is roughly ₹659 crore, but if the incremental revenue earns a wholesale-style 6-8% margin, the blended EBITDA margin only reaches about 6.2-6.6%. Reaching 8% requires a mix change, less low-margin trading revenue, and better absorption of fixed costs, plus the deleveraging that is already flowing through the PAT line. A path to 8% is evidenced and plausible. A path to 10% is not evidenced.

The peer comparison also exposes the growth gap. Priority's 14.58% revenue CAGR is the slowest of the four, against 38.6-58.0% for peers. Part of that is a recovery effect in the peer numbers, and Priority is the largest, most established pure-play lightweight manufacturer of the group. But it means Priority is growing with its market, roughly in line with or slightly above the ~15-17% industry growth, rather than stealing share at the speed of its smaller listed peers.

A large TAM, a small addressable share

The market study commissioned for the offer document puts the Indian light-weighted jewellery retail market at ₹2,74,824 crore in CY25, growing at a 14.71% CAGR to ₹5,45,792 crore by CY30. The closer fit for Priority's business, the diamond-studded gold wholesale market, is ₹40,280 crore in CY25, growing at a 16.89% CAGR to ₹87,906 crore by CY30. The organised segment is projected to exceed 40% of the market by CY30, and the industry has set a target of US$100 billion of jewellery exports by 2027. These are the numbers that justify the growth story.

The company's share of that market is not disclosed anywhere in the prospectus, which is itself worth noting. Dividing its FY26 revenue of ₹538.95 crore by the ₹40,280 crore TAM gives about 1.34%, but that is misleading, because half of the revenue is exports and a large part of the diamonds-and-stones line is trading-style. The honest addressable-share figures are lower: about 0.68% using domestic revenue only, and about 0.75% using finished-jewellery revenue only. Priority is a small player in a growing market, not a leader. The ~17% growth rate is the industry's, not evidence of company-specific share gains.

That said, the runway is real even without share gains. If the company held roughly 0.75% of the CY30 diamond-studded wholesale market, that alone implies revenue of about ₹659 crore, versus ₹538.95 crore in FY26, before winning any share. The TAM supports a revenue-doubling story by the end of the decade on share-hold alone. What it does not do is prove that Priority is taking share, or that the industry's growth rate is the company's growth rate.

Growth triggers: proven, early, promised

Not every growth driver in the prospectus deserves equal weight. The useful division is between what is already visible in the numbers, what is early-stage, and what is promise:

The proven triggers are the entire story so far, and two of them carry caveats. The margin and deleveraging trigger is partly a capital-structure effect: the ₹75 crore debt repayment is a one-time step-up, and the interest-free promoter loan is preserved rather than retired. The subsidiaries, including the silver venture and the lab-grown diamond line, are real strategy but zero revenue, with consolidated minority-interest losses of ₹2.18 million in Q1 FY27 and ₹1.72 million in FY26. They should be treated as optionality, not as drivers.

Thirteen months of capital events, then the IPO

The transaction history is where the document's disclosures start to tell a second, quieter story about who the capital events benefited and at what price:

The pattern across the arc: cash and equity moved within and out of the promoter group at the low end of the valuation ladder, then external money came in higher. A promoter sold 10 lakh shares back to the company at ₹100 in March 2024, an outlay equal to about 169% of FY24 PAT and implying a company value of roughly ₹41.5 crore at the time. Thirteen months later came a 3:1 bonus and intra-family gifts, and then in February 2026 the same company placed shares with external investors at ₹190, implying a post-money value of roughly ₹255 crore, about 14.5 times FY26 PAT. The buyback price was roughly half of what the pre-IPO round paid, on a per-share basis, and four of the six promoters hold their shares at an average cost of ₹0.00 to ₹2.50. One pre-IPO investor, Plutus, holds a put that guarantees an 18% IRR if the IPO fails, extinguished at listing. Every transaction is disclosed, audited and legal. The sequence, read as a whole, is simply unusual: cash out to a promoter at the low end, a bonus and gifts, then external capital at a far higher price.

The governance layer around all of this is young. The company converted to a public limited company in February 2025, its three independent directors were appointed in March 2025 and regularised in April 2025, and the board committees were constituted in March 2025, about 17 months before the RHP. The whole independent oversight apparatus was built in one sprint ahead of the listing, which is structurally normal for an IPO but means it has no track record. The CFO is a promoter. The auditors issued an unmodified report, but the notes carry hygiene flags: income-tax adjustments the company could not fully reconcile, a ₹0.52 million VAT provision unchanged across all periods with no movement, recurring delayed statutory remittances, and 15 MCA filing challans from 2007-2015 that could not be located. The litigation load is light: two dormant matters, an ED summons to the chairman from 2022-2023 tied to a job-work customer of a former subsidiary, and an SFIO notice to a director from 2018 for a dormant company, neither with follow-up in years. Related-party transactions with customer and supplier entities are disclosed and de minimis in size.

Bull, base and bear

The three cases are not a forecast. They are the same evidence weighted differently.

Bull case. Revenue compounds in the mid-to-high teens on the export engine and customer diversification, with exports staying broad-based and the UAE channel intact. The 58-65% utilisation gap is filled rather than expanded, EBITDA margin reaches the 7.5-8% band through operating leverage, export mix and deleveraging, and at least one early-stage bet (silver or lab-grown diamonds) converts into a second leg. Cash conversion improves as the working-capital cycle contracts. The ₹75 crore repayment is held, not re-borrowed. Under these assumptions the stated strategy is roughly half-delivered: FY26 revenue of ₹538.95 crore at 80% utilisation implies about ₹659 crore of revenue with a ~7% margin, on a de-levered balance sheet.

Base case. Revenue grows with the ~15-17% market, which is what the 14.58% CAGR already looks like. EBITDA margin holds around 6.5-7%, with operating leverage offset by B2B pass-through pricing and gold-price volatility. Utilisation stays in the 60-70% range as capacity is added ahead of demand. Exports remain the growth engine but stay concentrated, and the top-10 customer share hovers around 50%. The interest saving lands once and the promoter loan continues its gradual repayment. PAT grows modestly faster than revenue. This is what the six most recent quarters support most directly.

Bear case. The utilisation decline is a demand signal, not only a mix artefact, and it is confirmed when the mix normalises. Export growth decelerates to single digits or the UAE share of exports re-concentrates, the top-10 customer base suffers another account event like the one that removed roughly 36% of the largest customer's purchases, and the early-stage bets stay revenue-less. The post-IPO debt repayment is followed by debt rebuilding as inventory and receivables grow, so the deleveraging proves temporary, and the promoter loan is called or repriced. Revenue growth slips toward single digits and the margin stalls below 6.5%. This is the case the cash-flow and concentration data keep pointing toward.

What to watch

The quarterly numbers that will separate these cases, in order of importance:

• Cash conversion (CFO/PAT). The single number that tells you whether reported profit is becoming cash. It has been negative or near-zero in three of the last four periods.
• Unit volume and utilisation together. Utilisation by weight falling further, below roughly 50%, without a unit-volume offset would make the utilisation story a demand problem, not a mix artefact.
• Export share and the UAE concentration. Whether exports stay above ~45% of revenue and whether UAE stays below ~40% of exports.
• Top-10 customer share and the largest customer. Whether the largest account stabilises or falls further, and whether top-10 concentration drifts back above ~50%.
• Working-capital days and inventory. Whether the 145-day cycle improves, and whether inventory keeps growing faster than revenue.
• The promoter loan balance. Whether it keeps falling, and whether new tranches stop being drawn.
• EBITDA margin and finance cost. Whether the 7% level holds and whether the interest saving is retained.

Is Priority a better business, or just reporting better numbers?

The honest answer is that it is both, and the article's job is to keep the two apart.

The business is genuinely improving. Export-led revenue is real, broad-based and diversifying. Unit volume is growing at close to 9% a year. Margins, ROE and leverage have all moved in the right direction over six quarters, and the underlying niche, lightweight diamond-studded B2B manufacturing for organised retail, is structurally favoured by the industry's outsourcing logic and a ~15-17% growth market. None of that is an illusion.

But part of what is being reported as improvement is not operating performance. The revenue growth includes a commodity-price and mix component that exceeds physical throughput. The margin improvement includes a one-time ₹75 crore debt repayment that saves roughly 17-37% of FY26 PAT in interest, and an interest-free promoter loan that subsidises reported profit by up to roughly 14% of PAT at its peak and which the IPO explicitly declines to retire. The profit growth has not converted into cash, the working-capital cycle that built the debt is untouched, and the largest customer has already demonstrated what an account event looks like.

The strongest reason to be bullish: the export engine is proven and diversifying (+67% in FY26, 49.1% of revenue, top-5 export concentration falling), and it sits in a niche with a genuine structural runway.

The strongest reason to be cautious: the profit story has not become a cash story. Cash conversion was 0.24x in FY25 and negative in FY24 and Q1 FY27, the balance sheet is funded by revolving working-capital debt and a zero-cost promoter loan, and the ₹75 crore repayment is a one-time step-up against a cycle built to re-borrow.

The most important unanswered question: who is the largest customer, and was its ~36% absolute decline deliberate de-risking or lost business? The prospectus withholds the name, and export versus domestic margins are also undisclosed, so the two biggest drivers of the story, the top account and the export channel, cannot be fully audited from outside.

The one metric to track every quarter: cash conversion (CFO/PAT). It is the single number that separates real earnings from a profit story supported by an interest-free related-party facility, one-time deleveraging, and a working-capital engine that has historically absorbed cash.

What would prove the bull case right: exports compounding in the mid-to-high teens after the +67% spike, EBITDA margin holding at or above 7%, CFO/PAT improving durably toward 0.7x, working-capital days falling, and at least one early-stage bet converting to revenue.

What would break the bull case: exports decelerating to single digits, EBITDA margin stalling below 6.5% for four quarters, CFO/PAT staying near zero or negative, utilisation sliding below 50% without a unit-volume offset, the promoter loan balance rising again, or the early-stage bets remaining revenue-less.

Priority Jewels is interesting precisely because its reported numbers are a blend of three things that can be separated with the data in the offer document: a real export-led volume and mix shift, a one-time financial step-up, and a subsidised capital structure. The question an investor has to answer is not whether the company is growing. It is whether the growth, once the mix, the gold price, the debt repayment and the interest-free loan are stripped out, is still growing. The evidence so far says yes, but by less than the headline, and with a cash flow statement that has not yet agreed.

Frequently asked questions

What does Priority Jewels actually do?
It is a Mumbai-based B2B manufacturer of lightweight, affordable diamond-studded gold and platinum jewellery. It buys gold and diamonds, manufactures on its own account, and sells wholesale to chains like CaratLane, Kalyan Jewellers, Reliance Retail, Malabar Gold and Diamonds FZCO, TBZ and Senco, plus exports to 13 countries. It has no stores, no consumer brand and no job-work line.

Is Priority's revenue growth real volume growth?
Partly. Units processed grew at an 8.83% CAGR over FY24-FY26, which is genuine volume, while revenue grew at a 14.58% CAGR. The residual, roughly 5.3% a year, is price and mix, driven by lighter pieces, higher diamond content and a fast-growing diamonds-and-stones line. Gold output by weight actually fell 21% over the same two years.

Why is Priority's EBITDA margin lower than RBZ Jewellers?
RBZ is a different business model: it blends retail (roughly a third of sales, with 12-14% gross margins) with job work on retailer-supplied gold and a high-margin antique bridal product line. Priority is pure wholesale manufacturing plus a trading-style diamonds-and-stones segment, a structural mix that caps the blended margin near 6-7%.

Why is capacity utilisation falling while the company expands?
Utilisation by weight fell from 83% to 58% because the product mix shifted to lighter, higher-diamond-content pieces and to a diamonds-and-stones line that bypasses gold capacity. That is partly a mix artefact. But the company is adding floors and machinery at its MIDC plant with no disclosed investment amount or order visibility, and the offer document itself flags under-utilisation of expanded capacity as a risk.

What is the ₹75 crore debt repayment about?
About 75% of the IPO net proceeds will repay working-capital borrowings, saving roughly ₹3.0 to ₹6.6 crore a year in interest, about 17-37% of FY26 PAT. It is a genuine deleveraging, but the 145-172 day working-capital cycle is untouched, so the debt could rebuild as inventory and receivables grow.

What is the promoter loan?
The chairman and managing director has lent the company interest-free, unsecured, on-demand money, ₹13.08 crore at June 2026 after peaking at ₹30.34 crore. At a market rate of about 8% it would have cost up to roughly 14% of FY26 PAT. The IPO's general corporate purposes are barred from repaying it, so the subsidy is preserved rather than retired.

What is the most important metric to track every quarter?
Cash conversion, operating cash flow divided by PAT. It has been 0.24x in FY25 and negative in FY24 and Q1 FY27, and it is the single number that separates real earnings from a profit story carried by working-capital debt and an interest-free related-party loan.

Data note

All company financials are from the Red Herring Prospectus dated August 22, 2026 and the restated financials it contains (FY24 and FY25 restated; FY26 onward consolidated, including newly incorporated subsidiaries). The market and TAM figures are from the CARE industry report commissioned for the offer. Peer margins, leverage and growth figures combine prospectus-disclosed peer financials with listed-market data as of August 28, 2026; the Ashapuri figure carries a data flag and should be treated with care. Figures described as estimates (the price/mix split, revenue per kilogram scenarios, TAM shares, interest savings, and the implied cost of the promoter loan) are computed from the disclosed numbers, not reported by the company. The prospectus does not disclose the identity of the largest customer, a company-level market share, export versus domestic margins, or the investment amount and expected capacity of the MIDC expansion.

This article is factual, historical and descriptive analysis for educational purposes, not a recommendation to buy, sell or subscribe to any security, and it is not prepared by a SEBI-registered research analyst.

Not investment advice.